ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) /

The profitability of ADAPTIVE BIOTECHNOLOGIES CORPORATION over the past 9 years

Chart ADAPTIVE BIOTECHNOLOGIES CORPORATION: gross profit, operating income, net income, fiscal 2017–2025 Open the chart →

ADAPTIVE BIOTECHNOLOGIES CORPORATION reported a net loss of $59.5M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $205.62M and an operating loss of $57.12M. It reported a loss in all 9 years shown.

Year by year

Fiscal yearGross profitOperating incomeNet income
2025ended Dec 31, 2025$205.62M*-$57.12M-$59.5M
2024ended Dec 31, 2024$106.88M*-$162.55M-$159.49M
2023ended Dec 31, 2023$94.72M*-$227.03M-$225.25M
2022ended Dec 31, 2022$127.4M*-$200.19M-$200.19M
2021ended Dec 31, 2021$105.04M*-$208.97M-$207.28M
2020ended Dec 31, 2020$75.85M*-$152.82M-$146.23M
2019ended Dec 31, 2019$62.8M*-$78.39M-$68.61M
2018ended Dec 31, 2018$35.99M*-$49.76M-$46.45M
2017ended Dec 31, 2017$22.77M*-$44.48M-$42.83M

Fiscal years as ADAPTIVE BIOTECHNOLOGIES CORPORATION reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on ADAPTIVE BIOTECHNOLOGIES CORPORATION

Companies of a similar size

Not investment advice. This page shows what ADAPTIVE BIOTECHNOLOGIES CORPORATION filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.